About Technology Issues FAQ

Links

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.